Latest in Playable Version

Sort by

3 items

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next two to three months.
CNBC - 6h
Why Democrats’ Version of ‘Stop the Steal’ Isn’t Taking Off

A movement by some Democratic voters to investigate the results of the 2024 presidential election mirrors a push by Republicans in 2020. But it’s struggling.
The New York Times - 5d
FDA approves generic version of Novo Nordisk's GLP-1 diabetes drug Victoza

The Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug Victoza, which is currently in shortage in the country.
NBC News - 1d

FDA says the Zepbound shortage is over. Here’s what that means for compounding pharmacies, patients who used off-brand versions